16th Community Wide Experiment on the
Critical Assessment of Techniques for Protein Structure Prediction
Target: L3000
Target: L3000
Type: All-group target
Is protein multimer? No
Is CAPRI target? No
Is ligand target? Yes
Entry Date: 2024-05-03
Server Expiration Date: 2024-07-21
Human Expiration Date: 2024-08-04

Protein: Autotaxin
Organism:
Residues: 846
Method: X-RAY
Additional Information: The Autotaxin dataset, generously provided by F. Hoffmann-La Roche AG (Basel, CH), contains in total 219 protein-ligand(s) complexes after preparation. --- Tasks: 93 protein-ligand(s) complexes: BOTH Pose (P) and Affinity (A) prediction; 96 protein-ligand(s) complexes: ONLY Pose (P) prediction; 30 protein-ligand(s) complexes: ONLY Affinity (A) prediction. --- The stereochemistry is known and is provided for all the ligands for P and PA tasks but not for A tasks. The protonation state provided might not be optimal and would need to be determined. Some protein-ligand(s) complexes have more than one ligand present in the active site (22 protein-ligand(s) complexes in total). Molecules located nearby (< 4.5 A) the main ligand(s) and interacting with specific or non-specific interactions were also included in the SMILES files (.tsv). --- The autotaxin protein carries an N-glycosylation on residue Asn497, and was considered part of the structure (see pdb id 5m7m as an example). It also contains multiple ions: 2 zinc ions are present in the active site. These ions were also considered part of the autotaxin structure. The position of the carbohydrate and ions will not be taken into account for the final scoring. --- Reference: https://doi.org/10.3389/fphar.2021.699535 --- Predicted protein-ligand complexes should be submitted in CASP LG format through a special ligand submission gateway: https://predictioncenter.org/casp16/predictions_submission_LG.cgi .
Sequence: (Plain text version)
Template: (Plain text version)
Ligand SMILES: (L3000.SMILES.tar.gz)
Protein Structure Prediction Center
Sponsored by the US National Institute of General Medical Sciences (NIH/NIGMS)
Please address any questions or queries to:
© 2007-2024, University of California, Davis
Terms of Use